Global Adeno-Associated Virus (AAV) Gene Therapy Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
ReportID: 1109981
|
Published Date: 2024/07/06
|
No. of Pages: 165
|
Categories: IT & Telecommunication
|
Format : 
The A2Z Market Research report on “Global Adeno-Associated Virus (AAV) Gene Therapy Market Report 2023 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029” offers strategic visions into the global Adeno-Associated Virus (AAV) Gene Therapy market along with the market size (Volume – Million Units and Revenue – US$ Billion) and estimates for the duration 2023 to 2029. The said research study covers in-depth analysis of multiple market segments based on type, application, and studies different topographies. The report is also inclusive of competitive profiling of the leading Adeno-Associated Virus (AAV) Gene Therapy product vendors, and their latest developments.
This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2023 to 2029. The study highlights current market trends for Adeno-Associated Virus (AAV) Gene Therapy and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global Adeno-Associated Virus (AAV) Gene Therapy market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the Adeno-Associated Virus (AAV) Gene Therapy market.
By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2029 for all the regions and sub-regions have also been provided in the report.
This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global Adeno-Associated Virus (AAV) Gene Therapy market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.
Some of the important players in Adeno-Associated Virus (AAV) Gene Therapy market are:
Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio
Market segmentation by Type:
Luxturna
Zolgensma
Others
Market segmentation by Application:
Central Nervous System Diseases
Ocular Diseases
Liver-directed Diseases
Other Hereditary Diseases
This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2023 to 2029. The study highlights current market trends for Adeno-Associated Virus (AAV) Gene Therapy and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global Adeno-Associated Virus (AAV) Gene Therapy market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the Adeno-Associated Virus (AAV) Gene Therapy market.
By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2029 for all the regions and sub-regions have also been provided in the report.
This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global Adeno-Associated Virus (AAV) Gene Therapy market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.
Some of the important players in Adeno-Associated Virus (AAV) Gene Therapy market are:
Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio
Market segmentation by Type:
Luxturna
Zolgensma
Others
Market segmentation by Application:
Central Nervous System Diseases
Ocular Diseases
Liver-directed Diseases
Other Hereditary Diseases
Table of Content
Global Adeno-Associated Virus (AAV) Gene Therapy Market Research Report 2023 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
Chapter 1 Adeno-Associated Virus (AAV) Gene Therapy Market Overview
1.1 Product Overview and Scope of Adeno-Associated Virus (AAV) Gene Therapy
1.2 Adeno-Associated Virus (AAV) Gene Therapy Market Segmentation by Type
1.2.1 Global Production Market Share of Adeno-Associated Virus (AAV) Gene Therapy by Type in 2023
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Adeno-Associated Virus (AAV) Gene Therapy Market Segmentation by Application
1.3.1 Adeno-Associated Virus (AAV) Gene Therapy Consumption Market Share by Application in 2023
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Adeno-Associated Virus (AAV) Gene Therapy Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Adeno-Associated Virus (AAV) Gene Therapy (2018-2029)
Chapter 2 Global Economic Impact on Adeno-Associated Virus (AAV) Gene Therapy Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global Adeno-Associated Virus (AAV) Gene Therapy Market Competition by Manufacturers
3.1 Global Adeno-Associated Virus (AAV) Gene Therapy Production and Share by Manufacturers (2023 and 2023)
3.2 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue and Share by Manufacturers (2023 and 2023)
3.3 Global Adeno-Associated Virus (AAV) Gene Therapy Average Price by Manufacturers (2023 and 2023)
3.4 Manufacturers Adeno-Associated Virus (AAV) Gene Therapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Adeno-Associated Virus (AAV) Gene Therapy Market Competitive Situation and Trends
3.5.1 Adeno-Associated Virus (AAV) Gene Therapy Market Concentration Rate
3.5.2 Adeno-Associated Virus (AAV) Gene Therapy Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue (Value) by Region (2018-2023)
4.1 Global Adeno-Associated Virus (AAV) Gene Therapy Production by Region (2018-2023)
4.2 Global Adeno-Associated Virus (AAV) Gene Therapy Production Market Share by Region (2018-2023)
4.3 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue (Value) and Market Share by Region (2018-2023)
4.4 Global Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
4.5 North America Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
4.6 Europe Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
4.7 China Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
4.8 Japan Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
4.9 Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
4.10 India Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
Chapter 5 Global Adeno-Associated Virus (AAV) Gene Therapy Supply (Production), Consumption, Export, Import by Regions (2018-2023)
5.1 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption by Regions (2018-2023)
5.2 North America Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption, Export, Import by Regions (2018-2023)
5.3 Europe Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption, Export, Import by Regions (2018-2023)
5.4 China Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption, Export, Import by Regions (2018-2023)
5.5 Japan Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption, Export, Import by Regions (2018-2023)
5.6 Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption, Export, Import by Regions (2018-2023)
5.7 India Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption, Export, Import by Regions (2018-2023)
Chapter 6 Global Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue (Value), Price Trend by Type
6.1 Global Adeno-Associated Virus (AAV) Gene Therapy Production and Market Share by Type (2018-2023)
6.2 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue and Market Share by Type (2018-2023)
6.3 Global Adeno-Associated Virus (AAV) Gene Therapy Price by Type (2018-2023)
6.4 Global Adeno-Associated Virus (AAV) Gene Therapy Production Growth by Type (2018-2023)
Chapter 7 Global Adeno-Associated Virus (AAV) Gene Therapy Market Analysis by Application
7.1 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption and Market Share by Application (2018-2023)
7.2 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Growth Rate by Application (2018-2023)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Adeno-Associated Virus (AAV) Gene Therapy Manufacturing Cost Analysis
8.1 Adeno-Associated Virus (AAV) Gene Therapy Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Adeno-Associated Virus (AAV) Gene Therapy
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Adeno-Associated Virus (AAV) Gene Therapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Adeno-Associated Virus (AAV) Gene Therapy Major Manufacturers in 2023
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global Adeno-Associated Virus (AAV) Gene Therapy Market Forecast (2023-2029)
12.1 Global Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue Forecast (2023-2029)
12.2 Global Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption Forecast by Regions (2023-2029)
12.3 Global Adeno-Associated Virus (AAV) Gene Therapy Production Forecast by Type (2023-2029)
12.4 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Forecast by Application (2023-2029)
12.5 Adeno-Associated Virus (AAV) Gene Therapy Price Forecast (2023-2029)
Chapter 13 Appendix
Global Adeno-Associated Virus (AAV) Gene Therapy Market Research Report 2023 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
Chapter 1 Adeno-Associated Virus (AAV) Gene Therapy Market Overview
1.1 Product Overview and Scope of Adeno-Associated Virus (AAV) Gene Therapy
1.2 Adeno-Associated Virus (AAV) Gene Therapy Market Segmentation by Type
1.2.1 Global Production Market Share of Adeno-Associated Virus (AAV) Gene Therapy by Type in 2023
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Adeno-Associated Virus (AAV) Gene Therapy Market Segmentation by Application
1.3.1 Adeno-Associated Virus (AAV) Gene Therapy Consumption Market Share by Application in 2023
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Adeno-Associated Virus (AAV) Gene Therapy Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Adeno-Associated Virus (AAV) Gene Therapy (2018-2029)
Chapter 2 Global Economic Impact on Adeno-Associated Virus (AAV) Gene Therapy Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global Adeno-Associated Virus (AAV) Gene Therapy Market Competition by Manufacturers
3.1 Global Adeno-Associated Virus (AAV) Gene Therapy Production and Share by Manufacturers (2023 and 2023)
3.2 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue and Share by Manufacturers (2023 and 2023)
3.3 Global Adeno-Associated Virus (AAV) Gene Therapy Average Price by Manufacturers (2023 and 2023)
3.4 Manufacturers Adeno-Associated Virus (AAV) Gene Therapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Adeno-Associated Virus (AAV) Gene Therapy Market Competitive Situation and Trends
3.5.1 Adeno-Associated Virus (AAV) Gene Therapy Market Concentration Rate
3.5.2 Adeno-Associated Virus (AAV) Gene Therapy Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue (Value) by Region (2018-2023)
4.1 Global Adeno-Associated Virus (AAV) Gene Therapy Production by Region (2018-2023)
4.2 Global Adeno-Associated Virus (AAV) Gene Therapy Production Market Share by Region (2018-2023)
4.3 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue (Value) and Market Share by Region (2018-2023)
4.4 Global Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
4.5 North America Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
4.6 Europe Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
4.7 China Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
4.8 Japan Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
4.9 Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
4.10 India Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue, Price and Gross Margin (2018-2023)
Chapter 5 Global Adeno-Associated Virus (AAV) Gene Therapy Supply (Production), Consumption, Export, Import by Regions (2018-2023)
5.1 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption by Regions (2018-2023)
5.2 North America Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption, Export, Import by Regions (2018-2023)
5.3 Europe Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption, Export, Import by Regions (2018-2023)
5.4 China Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption, Export, Import by Regions (2018-2023)
5.5 Japan Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption, Export, Import by Regions (2018-2023)
5.6 Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption, Export, Import by Regions (2018-2023)
5.7 India Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption, Export, Import by Regions (2018-2023)
Chapter 6 Global Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue (Value), Price Trend by Type
6.1 Global Adeno-Associated Virus (AAV) Gene Therapy Production and Market Share by Type (2018-2023)
6.2 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue and Market Share by Type (2018-2023)
6.3 Global Adeno-Associated Virus (AAV) Gene Therapy Price by Type (2018-2023)
6.4 Global Adeno-Associated Virus (AAV) Gene Therapy Production Growth by Type (2018-2023)
Chapter 7 Global Adeno-Associated Virus (AAV) Gene Therapy Market Analysis by Application
7.1 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption and Market Share by Application (2018-2023)
7.2 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Growth Rate by Application (2018-2023)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Adeno-Associated Virus (AAV) Gene Therapy Manufacturing Cost Analysis
8.1 Adeno-Associated Virus (AAV) Gene Therapy Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Adeno-Associated Virus (AAV) Gene Therapy
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Adeno-Associated Virus (AAV) Gene Therapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Adeno-Associated Virus (AAV) Gene Therapy Major Manufacturers in 2023
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global Adeno-Associated Virus (AAV) Gene Therapy Market Forecast (2023-2029)
12.1 Global Adeno-Associated Virus (AAV) Gene Therapy Production, Revenue Forecast (2023-2029)
12.2 Global Adeno-Associated Virus (AAV) Gene Therapy Production, Consumption Forecast by Regions (2023-2029)
12.3 Global Adeno-Associated Virus (AAV) Gene Therapy Production Forecast by Type (2023-2029)
12.4 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Forecast by Application (2023-2029)
12.5 Adeno-Associated Virus (AAV) Gene Therapy Price Forecast (2023-2029)
Chapter 13 Appendix
Published On:2024/07/06
Base Year:
Historical Data:
No of Pages:165
Price
Global Adeno-Associated Virus (AAV) Gene Therapy Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
